317 related articles for article (PubMed ID: 17456509)
41. pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease.
de Vries M; van der Horst-Bruinsma I; van Hoogstraten I; van Bodegraven A; von Blomberg BM; Ratnawati H; Dijkmans B
J Rheumatol; 2010 Nov; 37(11):2340-4. PubMed ID: 20810508
[TBL] [Abstract][Full Text] [Related]
42. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
[TBL] [Abstract][Full Text] [Related]
43. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
Buckland MS; Mylonaki M; Rampton D; Longhurst HJ
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1328-30. PubMed ID: 16275949
[TBL] [Abstract][Full Text] [Related]
44. Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1.
Yacyshyn BR; Schievella A; Sewell KL; Tami JA
Clin Exp Immunol; 2005 Jul; 141(1):141-7. PubMed ID: 15958080
[TBL] [Abstract][Full Text] [Related]
45. Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?
Malickova K; Lukas M; Donoval R; Sandova P; Janatkova I
Clin Lab; 2006; 52(11-12):631-8. PubMed ID: 17175895
[TBL] [Abstract][Full Text] [Related]
46. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.
Hui T; Landers C; Vasiliauskas E; Abreu M; Dubinsky M; Papadakis KA; Price J; Lin YC; Huiying Y; Targan S; Fleshner P
Dis Colon Rectum; 2005 Jun; 48(6):1254-62. PubMed ID: 15868228
[TBL] [Abstract][Full Text] [Related]
47. Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives.
Michielan A; Basso D; Martinato M; Pathak S; Banerjee A; Oliva L; Plebani M; Sturniolo GC; D'Incà R
Dig Liver Dis; 2013 Nov; 45(11):894-8. PubMed ID: 23477870
[TBL] [Abstract][Full Text] [Related]
48. Advances in clinical laboratory tests for inflammatory bowel disease.
Nakamura RM; Matsutani M; Barry M
Clin Chim Acta; 2003 Sep; 335(1-2):9-20. PubMed ID: 12927679
[TBL] [Abstract][Full Text] [Related]
49. Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease.
Tecnologica MAP Suppl; 1999 Jun; ():18-20. PubMed ID: 10848041
[No Abstract] [Full Text] [Related]
50. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
Torres J; Petralia F; Sato T; Wang P; Telesco SE; Choung RS; Strauss R; Li XJ; Laird RM; Gutierrez RL; Porter CK; Plevy S; Princen F; Murray JA; Riddle MS; Colombel JF
Gastroenterology; 2020 Jul; 159(1):96-104. PubMed ID: 32165208
[TBL] [Abstract][Full Text] [Related]
51. Serological markers in inflammatory bowel disease: a review of their clinical utility.
Barahona-Garrido J; Sarti HM; Barahona-Garrido MK; Hernández-Calleros J; Coss-Adame E; Garcia-Saenz SM; Yamamoto-Furusho JK
Rev Gastroenterol Mex; 2009; 74(3):230-7. PubMed ID: 19858012
[TBL] [Abstract][Full Text] [Related]
52. Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis.
Tyler AD; Milgrom R; Xu W; Stempak JM; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Silverberg MS
Clin Gastroenterol Hepatol; 2012 May; 10(5):507-12.e1. PubMed ID: 21963956
[TBL] [Abstract][Full Text] [Related]
53. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
54. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.
Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G
Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202
[TBL] [Abstract][Full Text] [Related]
55. Serological differentiation of inflammatory bowel diseases.
Conrad K; Schmechta H; Klafki A; Lobeck G; Uhlig HH; Gerdi S; Henker J
Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):129-35. PubMed ID: 11981336
[TBL] [Abstract][Full Text] [Related]
56. Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy.
Sładek M; Wasilewska A; Swiat A; Cmiel A
Prz Gastroenterol; 2014; 9(4):232-41. PubMed ID: 25276255
[TBL] [Abstract][Full Text] [Related]
57. Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts.
Bernstein CN; El-Gabalawy H; Sargent M; Landers C; Rawsthorne P; Elias B; Targan SR
Can J Gastroenterol; 2011 May; 25(5):269-73. PubMed ID: 21647462
[TBL] [Abstract][Full Text] [Related]
58. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
[TBL] [Abstract][Full Text] [Related]
59. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
Goren I; Yahav L; Tulchinsky H; Dotan I
Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
[TBL] [Abstract][Full Text] [Related]
60. Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease.
Simondi D; Mengozzi G; Betteto S; Bonardi R; Ghignone RP; Fagoonee S; Pellicano R; Sguazzini C; Pagni R; Rizzetto M; Astegiano M
Inflamm Bowel Dis; 2008 May; 14(5):645-51. PubMed ID: 18240283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
